Study Identifies Heart Risks in Glaxo's Avandia
Study Identifies Heart Risks in Glaxo’s Avandia. Dr. Steven Nissen, of the Cleveland Clinic, authored a controversial study identifying heart risks in GlaxoSmithKline’s Avandia diabetes drug. He talks to CNBC’s Mike Huckman.